Kidney Disease Market Size, Segments, and Trends by 2031
Kidney Disease Market: Strategic Insights
Kidney Disease Market
-
CAGR (2023 - 2031)8.0% -
Market Size 2021
US$ 91.16 Billion -
Market Size 2031
US$ 176.51 Billion
Market Dynamics
GROWTH DRIVERS
- Favorable Reimbursement Policy for Kidney Disease Treatments
- High Prevalence of Chronic Diseases Leading to Kidney Diseases
FUTURE TRENDS
- Rise in Preference for Advanced Hemodialysis Therapies
OPPORTUNITIES
- Increase in Preference for Robotic Surgeries for Kidney Diseases
Key Players
- Abbott Laboratories
- Amgen Inc
- F Hoffmann La Roche Ltd
- GlaxoSmithKline PLC
- Pfizer Inc
- Siemens Healthineers
- Sysmex Corporation
- Teva Pharmaceutical Industries Ltd
- Siemens Healthineers AG
- AbbVie Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product Type
- Diagnosis
- Treatment
End User
- Hospital
- Diagnostic Laboratories